✨ Your Portfolio is fetched and updated from zerodha.
Micro Hospitals

Nidan Laboratories And Healthcare Ltd.

NIDAN

Market Cap
₹28 Cr.
P/E
0.00

Nidan Laboratories And Healthcare Ltd.

  • Nidan Labs. & Health
  • Vimta Labs
  • Krsnaa Diagnostics
FAQs on Nidan Laboratories And Healthcare Ltd. Shareprice

Nidan Labs. & Health has given lower returns compared to its competitors.
Nidan Labs. & Health has grown at ~-22.04% over the last 3yrs while peers have grown at a median rate of 0.39%

Nidan Labs. & Health is not expensive.
Latest PE of Nidan Labs. & Health is 0.0, while 3 year average PE is 8.05.
Also latest EV/EBITDA of Nidan Labs. & Health is 0 while 3yr average is 5.23.

View FAQ's On Business
Growth Table
  • Nidan Laboratories And Healthcare Ltd.
  • Vimta Labs
  • Krsnaa Diagnostics
Balance Sheet
  • Nidan Laboratories And Healthcare Ltd.
  • Vimta Labs
  • Krsnaa Diagnostics
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Nidan Laboratories And Healthcare Ltd.
  • Vimta Labs
  • Krsnaa Diagnostics
Cash Flow
  • Nidan Laboratories And Healthcare Ltd.
  • Vimta Labs
  • Krsnaa Diagnostics
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Nidan Laboratories And Healthcare Ltd.
  • Vimta Labs
  • Krsnaa Diagnostics
Quarterly Results
  • Nidan Laboratories And Healthcare Ltd.
  • Vimta Labs
  • Krsnaa Diagnostics
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Nidan Laboratories And Healthcare Ltd. Financials

Balance sheet of Nidan Labs. & Health is moderately strong.

The debt of Nidan Labs. & Health is decreasing.
Latest debt of Nidan Labs. & Health is ₹8.97 Crs as of Sep-24.
This is less than Mar-24 when it was ₹9.35 Crs.

No, profit is decreasing.
The profit of Nidan Labs. & Health is -₹4.05 Crs for TTM, -₹3.23 Crs for Mar 2024 and ₹3.54 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Nidan Labs. & Health latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Capital Work in Progress, Inventory, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech